Inovio Pharmaceuticals Inc. Stock Rallies 8.3%, Outperforms Peers
Dow Jones2026/08/19 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. rallied 8.3% to $1.30 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.
This was the stock's eighth consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 56.4% short of its 52-week high of $2.98, which the company reached on September 9th.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Statera Biopharma Inc. fell 50.0% to $0.00, and Pfizer Inc. rose 3.63% to $28.24.
Trading volume totaled 6.8 million, compared to the 50-day average of 3.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 19, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro drifts toward the bottom of its range as US rate bets climb
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.
Crypto prices
More
